Skip to content

Multivariate Analysis of Serum High Sensitivity C-Reactive Protein in Patients With Acute Phase Stroke

Multivariate Analysis of Serum High Sensitivity C-Reactive Protein in Patients With Acute Phase Stroke

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02171858
Acronym
MAASP
Enrollment
28
Registered
2014-06-24
Start date
2013-06-30
Completion date
Unknown
Last updated
2014-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

National Institutes of Health Stroke Scale, Serum High Sensitivity C-Reactive Protein, Stroke

Keywords

Stroke, National Institutes of Health Stroke Scale, Serum high sensitivity C-Reactive Protein

Brief summary

Stroke is one of main causes of death and impairment worldwide. Objective of this study is to analyze serum High Sensitivity C-Reactive Protein in acute phase stroke in patients attended at Petróleos Mexicanos Hospital Central Sur de Alta Especialidad and to correlate with stroke extension and clinical features.

Interventions

None listed

Sponsors

Hospital Central Sur de Alta Especialidad
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients suspected of acute phase stroke who arrive to emergency room at our hospital * Patients affiliated to Petróleos Mexicanos medical system * Patients of any gender * Patients between 18 and 80 years old

Exclusion criteria

* Stroke provoked by angiographic procedure * Pregnancy * Patient under chemotherapy or radiotherapy * Recently surgery or trauma among last 30 days * Heparin usage * Stroke and/ or thrombolysis history * Active infection * Liver disease

Design outcomes

Primary

MeasureTime frameDescription
Measure of serum High sensitivity C-Reactive Protein levelwithin the first 8 hours since admission to hospitalSerum levels of serum High sensitivity C-Reactive Protein will be measured in patients with suspicion of stroke at the emergency room within the first 8 hours of arrival at our hospital

Secondary

MeasureTime frameDescription
National Institutes of Health Stroke Scalewithin the first 4 hours since admission to emergency roomclinical impact of stroke will be determined by neurology and neurosurgery department at admission to emergency room of our hospital

Other

MeasureTime frameDescription
Stroke extensionwithin the first 4 hours since admission to emergency roombrain image will be taken as soon as possible when patient suspected with stroke arrives to emergency room and after clinical evaluation
Origin of strokeorigin will be diagnosed during the hospital stay expecting no more than 1 weekorigin of stroke will be investigated within hospital stay
Hospital stayhospital stay is expected for no more than 1 week unless intensive care unit is neededfrom arrival of patient to emergency room until discharge

Countries

Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026